Login to Your Account



Nabi Raises $32.9M Privately To Fund PhosLo Acquisition

By Kim Coghill


Tuesday, July 15, 2003
Nabi Biopharmaceuticals intends to use proceeds generated through a $32.9 million private placement to help in its purchase of PhosLo and to pay for a Phase III confirmatory trial of StaphVAX. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription